REAL-TIME
BIOMARKER
TESTING FOR
HEALTH

THE BIG IDEA,
TO REVOLUTINIZE
DIAGNOSTICS

Measuring tens to hundreds of analytes simultaneously in 5 minutes will revolutionize healthcare.

eGlint Technology,

No More Compromising

PROTEONEX

TM

TECHNOLOGY

eGlint’s core ProteoNex™ technology is versatile, allowing it to measure combinations of virtually any biomarkers

General and
Quantitative

Quantifies virtually any biomarker from a drop of blood

Highly
Multiplexed

Performs hundreds of assays at once

Simple and
Rapid

Delivers results within minutes without sample purification

Affordable and
Scalable

Lowers cost per sample and dramatically lowers cost per biomarker

REAL-TIME SEPSIS TESTING

where others failed, we will prevail

Number of Americans

1.7M

affected by sepsis

[1]

Sepsis Causes

350,000

deaths per year in the US

[1]

Treating sepsis costs

$38B

in the US

[2]

1. https://www.cdc.gov/sepsis/what-is-sepsis.html
2. https://www.wolterskluwer.com/en/expert-insights/reviving-sepsis-care-to-achieve-millions-in-cost-savings

LEADERSHIP TEAM

MIENA ARMANIOUS, PHD

Founder and CTO

ERWIN ESTIGARRIBIA

CEO

DENIS MALYSHEV, PHD

Founder and COO

BRAD MACMULLIN, CPA

CFO

Board of Directors

RICHARD SHEN, PHD

Founding Investor

FLOYD ROMESBERG, PHD

Founder and Investor

JOE GATTO

Lead Investor

REAL-TIME
BIOMARKER
TESTING FOR
HEALTH

THE BIG IDEA,
TO REVOLUTINIZE
DIAGNOSTICS